The NCI-H441 cell line was established in 1982 from the pericardial fluid from a male patient with lung papillary adenocarcinoma. NCI-H441 cell line is hyperdiploid, has a modal chromosome number of 52, and can be cloned with or without serum in soft agar. NCI-H441 cells exhibit an epithelial morphology and adhere in culture. The NCI-H441 cell line expresses major surfactant apoprotein, mRNA, and pulmonary surfactant protein. NCI-H441 cells are suitable transfection hosts and can be used for lung cancer research and biomedical applications. An NCI-H441 transfection kit can be purchased through Altogen Biosystems to transfect NCI-H441 cells.
Altogen Biosystems is a quality provider and research corporation for biological laboratories. Custom biological services and supplementary preclinical items include siRNA screening, cell transfection optimization, quick cell line generation, liposome encapsulation and more. Dedicated to benefiting customers with useful and excellent services, Altogen Biosystems aims to advance modern pharmaceutical technologies. Visit Altogen for a comprehensive assortment of lung cancer xenograft models and related tools for biomedical research.